Correlates of symptom dimensions in schizophrenia obtained with the Spanish version of the Manchester Scale

Psychopathology

Volumn 33, Issue 5, 2000, Pages 259-264

  Tabarés, Rafael ^a   Sanjuán, Julio ^b   Gómez Beneyto, Manuel ^b   Leal, Carmen ^b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b NONE

Author keywords

Factor analysis; Schizophrenia; Symptom dimensions

Indexed keywords

ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISORIENTATION; FACTORIAL ANALYSIS; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MENTAL DISEASE; MORBIDITY; NEGATIVE SYNDROME; OUTPATIENT; RATING SCALE; SCHIZOPHRENIA;

EID: 0033798471     PISSN: 02544962     EISSN: None     Source Type: Journal    
DOI: 10.1159/000029155     Document Type: Article

References (39)

1. Dollfus S, Brazo P: Clinical heterogeneity of schizophrenia. Psychopathology 1997;30:275-281.
2. Crow TJ: Molecular pathology of schizophrenia: More than one disease process? BMJ 1980; 280:66-68.
3. Liddle PF: The symptoms of chronic schizophrenia. A reexamination of the positive-negative dichotomy. BrJ Psychiatry 1987;151:145-151.
4. Peralta V, de León J, Cuesta MJ: Are there more than two syndromes in schizophrenia: A critique of positive-negative dichotomy. Br J Psychiatry 1992;161:335-343.
5. White L, Harvey PD, Opler L, Lindenmayer JP, the PANSS study group: Empirical assessment of the factorial structure of clinical symptoms in schizophrenia. Psychopathology 1997; 30:263-274.
6. Andreasen NC, Roy MA, Flaum M: Positive and negative symptoms; in Hirsch SR, Weinberger DR (eds): Schizophrenia. Oxford, Blackwell Science, 1995, pp 28-45.
7. Lewis S: Psychopathology and brain dysfunction: Structural imaging studies; in Keshavan MS, Murray RM (eds): Neurodevelopment and Adult Psychopathology. Cambridge, Cambridge University Press, 1997, pp 178-186.
8. Perez-Fuster A, Ballester M, Girón M, Gómez-Beneyto M: Estructura factorial y consistencia interna de la escala de evaluación psiquiatrica de Krawiecka. Actas Luso-Esp Neurol Psiquiatr 1989;17:25-31.
9. Krawiecka M, Goldberg D, Vaughan M: A standardized psychiatric assessment scale for rating chronic psychotic patients. Acta Psychiatr Scand 1977;55:299-308.
10. Barnes THRE: The assessment of negative symptoms; in Barnes THRE, Nelson HE (eds): The Assessment of Psychoses. A Practical Handbook. London, Chapman & Hall Medical, 1994, pp 51-70.
11. Lobo A: El miniexamen cognoscitivo (un test seneillo, practice para detectar alteraciones intelectuales en pacientes médicos). Actas Luso-Esp Neurol Psiquiatr 1979;7:189-202.
12. Andreasen NC, et al: The family history method using diagnostic criteria. Arch Gen Psychiatry 1977;34:1229-1235.
13. Alvarez E, Garcia-Ribera C, Torrens M, et al: Premorbid adjustment scale as a prognostic predictor for schizophrenia. Br J Psychiatry 1987;168:411.
14. Cannon-Spoor HE, Potkin SG, Wyatt RJ: Measurement of premorbid adjustment in chronic schizophrenia. Schizophr Bull 1982;8:470-484.
15. Tress B, Desmond P: Computed tomography; in Ames D, Chiu E (eds): Neuroimaging and the Psychiatry of Late Life. Cambridge, Cambridge University Press, 1997, pp 3-22.
16. Barcia D, Galiana M, Lopez L: Neurolépticos: in López-Ibor JJ, Ruiz C, Barcia D (eds): Psiquiatria. Barcelona, Toray, 1982, vol 2, pp 1305-1326.
17. Jackson HJ, Burgess PM, Minas IH, Joshua SD: Psychometric properties of the Manchester scale. Acta Psychiatr Scand 1990;81:108-113.
18. Johnstone EC, Frith CD: Validation of three dimensions of schizophrenic symptoms in a large unsclected sample of patients. Psychol Med 1996;26:669-679.
19. Van der Does AJW, Dingemans PMAJ, Linszen DH, Nugter MA, Scholte WF: Dimensions and subtypes of recent-onset schizophrenia. A longitudinal analysis. J Nerv Ment Dis 1995; 183:681-687.
20. Mellers JDC, Sham P, Jones PB, Toone BK, Murray RM: A factor analytic study of symptoms in acute schizophrenia. Acta Psychiatr Scand 1996;93:92-98.
21. Liddle PF: Schizophrenic syndromes, cognitive performance and neurological dysfunctions. Psychol Med 1987;17:49-57.
22. Lenzenweger MF, Dworkin RH: The dimersions of schizophrenia phenomenology. Br J Psychiatry 1996;168:432-440.
23. Peralta V, Cuesta MJ, de Leon J: Positive and negative symptoms/syndromes in schizophrenia: Reliability and validity of different diagnostic systems. Psychol Med 1995;25:43-50.
24. Bailer J, Brauner W, Rev ER: Premorbid adjustment as predictor of outcome in schizophrenia: Results of a prospective study. Acta Psychiatr Scand 1996;93:368-377.
25. Cannon TD, Mednick SA, Parnas J: Antecedents of predominantly negative and predominantly positive-symptom schizophrenia in a high-risk population. Arch Gen Psychiatry 1990;47:622-632.
26. Andreasen NC, Olsen SA, Denneart JW, Smith MR: Ventricular enlargement in schizophrenia: Relationship to positive and negative symptoms. Am J Psychiatry 1982;39:778-783.
27. Marks RC, Luchins DJ: Relationship between brain imaging findings in schizophrenia and psychopathology: A review of the literature to positive and negative symptoms: in Andreasen NC (ed): Schizophrenia: Positive and Negative Symptoms and Syndromes. Modern Problems of Pharmacopsychiatry. Basel, Karger, 1990, vol 24, pp 89-123.
28. Schröder J, Buchsbaum MS, Siegel BV, Geider FJ, Niethammer R: Structural and functional correlates of subsyndromes in chronic schizophrenia. Psychopathology 1995;28:38-45.
29. Johnstone EC, Crow TJ, Frith CD, Husband J, Kreel L: Cerebral ventricular size and cognitive impairment in chronic schizophrenia. Lancet 1976;ii:924-926.
30. D'Amato T, Rochet T, Dalery J, Chauchat JH, Terra JL, Arteaga C, Marie-Cardine M: Anomalies tomodensitométriques dans la schizophrénie. Encéphale 1992;18:175-179.
31. Vázquez-Barquero JL, Nuñez MJC, Pando FQ, De La Varga M, Castanedo SH, Dunn G: Structural abnormalities of the brain in schizophrenia: Sex differences in the Cantabria first episode of schizophrenia study. Psychol Med 1995;25:1247-1258.
32. Rubin P: Neurobiological findings in first admission patients with schizophrenia or schizophreniform disorder. Dan Med Bull 1997; 44:140-154.
33. Seno H, Shibata M, Fujimoto A, Kuroda H, Kanno H. Ishino H: Computed tomographic study of aged schizophrenic patients. Psychiatry Clin Neurosci 1997;51:373-377.
34. Andreasen NC, Arndt S, Alliger R, Del Miller, Flaum M: Symptoms of schizophrenia. Arch Gen Psychiatry 1995;52:352-360.
35. Vita A, Dieci M, Giobbio GM, Tenconi F, Invernizzi G: Time course of cerebral ventricular enlargement in schizophrenia supports the hypothesis of its neurodevelopmental nature. Schizophr Res 1997;23:25-30.
36. Tabarés R, Pallardó Y, Cervera V, Leal C: Estabilidad del tamaño de los ventrículos y área cerebral en la esquizofrenia: Un estudio de seguimienlo de 7 años con tomografía computarizada. Psiquiatr Biol 1997;4:10-14.
37. Nibuya M, Kanba S, Sekiya U, Suzuki E: Schizophrenic patients with deficit syndrome have higher plasma homovanillic acid concentrations and ventricular enlargement. Biol Psychiatry 1995:;38:50-56.
38. Cullberg J, Nyback H: Persistent auditory hallucinations correlate with size of the third ventricle in schizophrenic patients. Acta Psychiatr Scand 1992;86:469-472.
39. Hower WG, Smith GN, Lapointe JS, Mac Ewan GW, et al: Regional cortical anatomy and clozapine response in refractory schizophrenia. Neuropsychopharmacology 1995;13: 85-87.